Abstract | OBJECTIVE: METHODS: RF, ANAs, and ACPAs were measured by standard immunoturbidimetry, immunofluorescence assay, and enzyme-linked immunosorbent assay, respectively. Characterization of AAT phenotypes was performed by isoelectric focusing and immunofixation. The chi-square test with Yates' correction and the Mann-Whitney U test were used to assess the prevalence of alleles associated with AATD in RA and to compare mean antibody titers, respectively. RESULTS: Of 246 patients with RA, 24 who were heterozygous for AATD were identified, with no statistically significant difference in the prevalence of AATD between RA patients and the general population (P = 0.39). A positive association between heterozygosity for AATD and the production of ACPAs was observed (P < 0.0001), with increased ACPA titers recorded in the AATD RA cohort compared with the general population (P = 0.01). CONCLUSION: AAT heterozygous status in RA is strongly associated with positive ACPAs and may define a distinct subset of patients with increased disease severity.
|
Authors | Cormac McCarthy, Carl Orr, Laura T Fee, Tomás P Carroll, Danielle M Dunlea, David J L Hunt, Eimear Dunne, Paul O'Connell, Geraldine McCarthy, Dermot Kenny, Ursula Fearon, Douglas J Veale, Emer P Reeves, Noel G McElvaney |
Journal | Arthritis & rheumatology (Hoboken, N.J.)
(Arthritis Rheumatol)
Vol. 69
Issue 8
Pg. 1576-1579
(08 2017)
ISSN: 2326-5205 [Electronic] United States |
PMID | 28409899
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2017, American College of Rheumatology. |
Chemical References |
- Antibodies, Antinuclear
- Autoantibodies
- Peptides, Cyclic
- alpha 1-Antitrypsin
- cyclic citrullinated peptide
- Rheumatoid Factor
|
Topics |
- Antibodies, Antinuclear
(immunology)
- Arthritis, Rheumatoid
(epidemiology, genetics, immunology)
- Autoantibodies
(immunology)
- Case-Control Studies
- Genotype
- Humans
- Mutation
- Peptides, Cyclic
(immunology)
- Phenotype
- Polymorphism, Genetic
- Prevalence
- Rheumatoid Factor
(immunology)
- alpha 1-Antitrypsin
(genetics)
- alpha 1-Antitrypsin Deficiency
(epidemiology, genetics)
|